ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
INTUITIVE SURGICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$433.18+6.48 (+1.52%)
Close on Oct 19, 2026
- Market cap
- $154.78B
- P/E (TTM)
- 49.6
- Dividend yield
- –
Share price
−$12.95 (−2.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
INTUITIVE SURGICAL INC grew revenue 20.7% to $11.03B over the twelve months to Jun 30, 2026. Operating income rose 31.0% to $3.45B, moving the operating margin from 28.8% to 31.3%. Free cash flow was $3.22B, up 61.6% from a year earlier.
Revenue
$11.03B
+20.7% vs. a year earlier
Operating income
$3.45B
+31.0% vs. a year earlier
Free cash flow
$3.22B
+61.6% vs. a year earlier
EPS, diluted
$8.73
+21.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $154.78B
- P/E ratio
- 49.6
- Price to sales
- 14.03
- Price to book
- 8.52
- Dividend yield
- –
- Free cash flow yield
- 2.08%
Fundamentals
- Revenue
- $11.03B
- Net income
- $3.14B
- EPS, diluted
- $8.73
- Free cash flow
- $3.22B
- Book value per share
- $50.85
- Diluted shares
- 357M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$11.03B+20.7% YoY
Gross profit
$7.36B+20.8% YoY
Operating income
$3.45B+31.0% YoY
Net income
$3.14B+20.4% YoY
EPS, diluted
$8.73+21.8% YoY
Free cash flow
$3.22B+61.6% YoY
Reported periodTrailing twelve months